- Home
- ALAR vs MNOV Comparison
ALAR vs MNOV Comparison
Compare ALAR & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- MNOV
- Stock Information
- Founded
- ALAR 2013
- MNOV 2000
- Country
- ALAR Israel
- MNOV United States
- Employees
- ALAR N/A
- MNOV N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- ALAR Technology
- MNOV Health Care
- Exchange
- ALAR Nasdaq
- MNOV Nasdaq
- Market Cap
- ALAR 70.7M
- MNOV 97.1M
- IPO Year
- ALAR 2018
- MNOV 2005
- Fundamental
- Price
- ALAR $9.19
- MNOV $1.95
- Analyst Decision
- ALAR Strong Buy
- MNOV
- Analyst Count
- ALAR 2
- MNOV 0
- Target Price
- ALAR $25.50
- MNOV N/A
- AVG Volume (30 Days)
- ALAR 194.9K
- MNOV 26.4K
- Earning Date
- ALAR 11-26-2024
- MNOV 11-07-2024
- Dividend Yield
- ALAR N/A
- MNOV N/A
- EPS Growth
- ALAR N/A
- MNOV N/A
- EPS
- ALAR 0.07
- MNOV N/A
- Revenue
- ALAR $31,117,000.00
- MNOV $1,000,000.00
- Revenue This Year
- ALAR $22.15
- MNOV N/A
- Revenue Next Year
- ALAR $11.59
- MNOV N/A
- P/E Ratio
- ALAR $17.34
- MNOV N/A
- Revenue Growth
- ALAR 52.26
- MNOV N/A
- 52 Week Low
- ALAR $2.92
- MNOV $1.12
- 52 Week High
- ALAR $46.69
- MNOV $2.16
- Technical
- Relative Strength Index (RSI)
- ALAR 32.09
- MNOV 56.00
- Support Level
- ALAR $9.25
- MNOV $1.98
- Resistance Level
- ALAR $10.69
- MNOV $2.07
- Average True Range (ATR)
- ALAR 0.75
- MNOV 0.12
- MACD
- ALAR 0.23
- MNOV -0.02
- Stochastic Oscillator
- ALAR 2.25
- MNOV 69.39
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.